Arkolith/Insider Trading/DNTH/Form 4

Randhawa Simrat

EVP, Head of R&DDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Nov 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.4M
Net Open-Market Flow
-$7.4M
Transactions
14
9 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 14, 2025Option exercise(M)31K$22.07$690K113K
Nov 14, 2025Sell(S)109K$38.14$4.2M4K
Nov 14, 2025Option exercise(M)40K$17.88$720K44K
Nov 14, 2025Option exercise(M)37K$21.77$816K82K
Nov 13, 2025Option exercise(M)4K$17.88$63K92K
Nov 13, 2025Option exercise(M)84K$8.44$709K88K
Nov 13, 2025Sell(S)19K$37.72$701K4K
Nov 13, 2025Sell(S)43K$37.04$1.6M23K
Nov 13, 2025Sell(S)26K$35.80$937K65K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 14, 2025Option exercise(M)37K—$063K
Nov 14, 2025Option exercise(M)40K—$076K
Nov 14, 2025Option exercise(M)31K—$0119K
Nov 13, 2025Option exercise(M)4K—$0116K
Nov 13, 2025Option exercise(M)84K—$012K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001992260-25-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML